NLRP3 and stroke disorder: Growing evidence implicates elevated serum NLRP3 inflammasome levels as a potential predictor for malignant cerebral oedema post-ischemic stroke, though this association requires further validation in large-scale studies to account for potential confounding by stroke severity [36].